You are here

  • Home
  • Archive
  • Volume 52, Issue Suppl 2
  • MG-110 Intravenous neonatal gene therapy corrects GM2 gangliosidoses in sandhoff mice for ‘long-term’, by using an aav expressing a new hexosaminidase variant

Article metrics

Article menu
Download PDFPDF
Clinical Genetics
Posters MG-100 to MG-119
MG-110 Intravenous neonatal gene therapy corrects GM2 gangliosidoses in sandhoff mice for ‘long-term’, by using an aav expressing a new hexosaminidase variant

 

Online download statistics by month:

Online download statistics by month: January 2016 to September 2024

AbstractFullPdf
Jan 2016200
Feb 2016100
Mar 2016100
Apr 2016200
May 2016800
Jun 2016300
Jul 2016700
Aug 2016401
Sep 2016200
Oct 2016100
Nov 2016100
Jan 2017500
Feb 2017300
Mar 2017300
Jun 2017400
Aug 2017600
Sep 2017400
Oct 2017400
Nov 20171400
Dec 2017800
Jan 2018600
Feb 2018400
Mar 20181401
Apr 2018400
May 20183401
Jun 20181200
Jul 20181400
Aug 20181000
Sep 2018800
Oct 20181601
Nov 20182600
Dec 20181000
Jan 20191200
Feb 20191000
Mar 2019600
Apr 2019800
May 20191200
Jun 20191001
Jul 2019600
Aug 2019601
Sep 2019200
Oct 2019400
Nov 20191000
Dec 2019600
Jan 20201200
Feb 2020200
May 2020800
Jun 2020600
Jul 2020800
Aug 2020400
Sep 20201000
Oct 2020400
Nov 2020601
Dec 2020200
Jan 2021600
Oct 2021201
Nov 2021800
Dec 2021600
Jan 2022400
Feb 2022400
Mar 2022600
May 2022600
Jun 20221200
Jul 2022800
Aug 2022600
Sep 2022400
Oct 20221100
Nov 2022400
Dec 2022800
Jan 2023600
Feb 2023400
Mar 2023600
Apr 20231200
May 2023600
Jun 2023800
Jul 20231400
Aug 2023200
Sep 20231200
Nov 2023600
Dec 20231000
Jan 2024400
Feb 2024200
Mar 20241200
Apr 2024600
May 20241000
Jun 2024200
Jul 20241800
Aug 2024200
Sep 2024200
Total63408